Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Elevation Oncology ( (ELEV) ) is now available.
On March 31, 2025, Elevation Oncology announced that Chief Medical Officer Dr. Valerie M. Jansen stepped down from her position. Dr. Jansen will receive severance benefits as per her agreement with the company, including a lump-sum payment, healthcare coverage, and accelerated vesting of equity awards. This transition is part of a separation agreement that includes standard legal provisions, potentially impacting the company’s operational dynamics and stakeholder relations.
More about Elevation Oncology
Elevation Oncology, Inc. operates in the biotechnology industry, focusing on the development of precision medicines for the treatment of cancer.
YTD Price Performance: -56.83%
Average Trading Volume: 2,627,012
Technical Sentiment Signal: Buy
Current Market Cap: $15.34M
See more data about ELEV stock on TipRanks’ Stock Analysis page.